期刊
ACS INFECTIOUS DISEASES
卷 8, 期 12, 页码 2396-2404出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsinfecdis.2c00307
关键词
polymyxin B; polymyxin B nonapeptide; mechanism of action; stereochemistry; enantiomers
资金
- European Research Council (ERC) [725523]
- European Research Council (ERC) [725523] Funding Source: European Research Council (ERC)
With increasing antibiotic resistance, there is renewed interest in polymyxins, a type of lipopeptide antibiotics with potent anti-Gram-negative activity. This study synthesized the full enantiomers of polymyxin B and the polymyxin B nonapeptide (PMBN) to investigate their mechanism of action. The enantiomeric species showed reduced antibacterial activity, lower LPS binding, lower outer membrane permeabilization, and loss of synergetic potential, providing new insights into the stereochemical requirements of polymyxin B and PMBN.
With increasing rates of resistance toward commonly used antibiotics, especially among Gram-negative bacteria, there is renewed interested in polymyxins. Polymyxins are lipopeptide antibiotics with potent anti-Gram-negative activity and are generally believed to target lipid A, the lipopolysaccharide (LPS) anchor found in the outer membrane of Gram-negative bacteria. To characterize the stereochemical aspects of their mechanism(s) of action, we synthesized the full enantiomers of polymyxin B and the polymyxin B nonapeptide (PMBN). Both compounds were compared with the natural compounds in biological and biophysical assays, revealing strongly reduced antibacterial activity for the enantiomeric species. The enantiomeric compounds also exhibit reduced LPS binding, lower outer membrane (OM) permeabilization, and loss of synergetic potential. These findings provide new insights into the stereochemical requirements underlying the mechanisms of action of polymyxin B and PMBN.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据